Telomerase catalytic subunit in laryngeal carcinogenesis - An immunohistochemical study

Modern Pathology

Volumn 18, Issue 3, 2005, Pages 406-411

  Luzar, Boštjan ^a   Poljak, Mario ^a   Gale, Nina ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Carcinogenesis; hTERT protein; Larynx; Ljubljana classification; Squamous cell carcinoma; Telomerase; Telomerase catalytic subunit

Indexed keywords

TELOMERASE;

ARTICLE; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SUBUNIT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX; LARYNX CANCER; PRIORITY JOURNAL; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LARYNX; PRECANCEROUS CONDITIONS; TELOMERASE;

EID: 15444379554     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800275     Document Type: Article

References (25)

1. Shippen-Lentz D, Blackburn EH. Functional evidence for RNA template in telomerase. Science 1990;247:546-552.
2. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995;269:1236-1241.
3. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-959.
4. Saito T, Matsuda Y, Suzuki T, et al. Comparative gene mapping of the human and mouse TEP1 genes, which encode one protein component of telomerases. Genomics 1997;46:46-50.
5. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997;90:85-95.
6. Ito H, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res 1998; 4:1603-1608.
7. Counter CM, Meyerson M, Eaton EN, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 1998;16:1217-1222.
8. Koyanagi Y, Kobayashi D, Yajima T, et al. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells. Anticancer Res 2000;20:773-778.
9. Kilian A, Bowtell DD, Abud HE, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997;6:2011-2019.
10. Ulaner GA, Hu JF, Vu TH, et al. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 2001;91:644-649.
11. Kotoula V, Hytiroglou P, Pyrpasopoulou A, et al. Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers. Liver 2002;22:57-69.
12. Luzar B, Poljak M, Marin IJ, et al. Telomerase reactivation is an early event in laryngeal carcinogenesis. Mod Pathol 2003;16:841-848.
13. Luzar B, Poljak M, Marin IJ, et al. Quantitative measurement of telomerase catalytic subunit (hTERT) mRNA in laryngeal squamous cell carcinomas. Anticancer Res 2001;21:4011-4015.
14. Shanmugaratnam K, Sobin LH. Histological typing of tumours of the upper respiratory tract and ear. World Health Organization-International Histological Classification of Tumours, 2nd edn. Springer Verlag: Berlin, 1991.
15. Hellquist H, Cardesa A, Gale N, et al. Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working Group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology. Histopathology 1999;34:226-233.
16. Gale N, Kambič V, Michaels L, et al. The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions. Adv Anat Pathol 2000;7:240-251.
17. Dhaene K, Van Marck E, Parwaresch R. Telomeres, telomerase and cancer: an up-date. Virchows Arch 2000;437:1-16.
18. Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999;59: 551-557.
19. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
20. van der Sanden GA, Coebergh JW, Schouten LJ, et al. Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer 1995;31A:1822-1829.
21. Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinogen 1993;7:139-146.
22. Kambič V, Gale N. Epithelial hyperplastic lesions of the larynx. Amsterdam: Elsevier, 1995.
23. Liu K, Schoonmaker MM, Levine BL, et al. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci USA 1999;96:5147-5152.
24. Fujimoto R, Kamata N, Yokoyama K, et al. Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral Oncol 2001;37:132-140.
25. Zidar N, Gale N, Cör A, et al. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. J Laryngol Otol. 1996;110:440-445.